OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 22 citing articles:

Selenization of Small Molecule Drugs: A New Player on the Board
Cristina Morán-Serradilla, Daniel Plano, Carmen Sanmartín, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7759-7787
Closed Access | Times Cited: 16

Computer-aided drug design in anti-cancer drug discovery: What have we learnt and what is the way forward?
Opeyemi Iwaloye, Paul Olamide Ottu, Femi Olawale, et al.
Informatics in Medicine Unlocked (2023) Vol. 41, pp. 101332-101332
Open Access | Times Cited: 28

Anticancer activity of new triazolopyrimidine linked coumarin and quinolone hybrids: Synthesis, molecular modeling, TrkA, PI3K/AKT and EGFR inhibition
Rasha Z. Batran, Eman Y. Ahmed, Eman S. Nossier, et al.
Journal of Molecular Structure (2024) Vol. 1305, pp. 137790-137790
Closed Access | Times Cited: 9

Synthesis, antitumor activity, antimicrobial evaluation and molecular docking studies of some hydrazone, 1,3,4-oxadiazole, 1,2,4-triazole and pyrazole derivatives bearing nicotinoyl moiety
Abdel‐Rahman Farghaly, Saleh A. Ahmed, Khatib Sayeed Ismail, et al.
Results in Chemistry (2024) Vol. 7, pp. 101474-101474
Open Access | Times Cited: 5

Designing Potent Anti-Cancer Agents: Synthesis and Molecular Docking Studies of Thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidine Derivatives
Eman S. M. Elsenbawy, Zafer Saad Alshehri, Nouf A. Babteen, et al.
Molecules (2024) Vol. 29, Iss. 5, pp. 1067-1067
Open Access | Times Cited: 2

Novel imidazolone derivatives as potential dual inhibitors of checkpoint kinases 1 and 2: Design, synthesis, cytotoxicity evaluation, and mechanistic insights
Yasmin S. Sheta, Marwa T. Sarg, Fatma G. Abdulrahman, et al.
Bioorganic Chemistry (2024) Vol. 149, pp. 107471-107471
Closed Access | Times Cited: 2

New sulfonamide-based glycosides incorporated 1,2,3-triazole as cytotoxic agents through VEGFR-2 and carbonic anhydrase inhibitory activity
Hebat‐Allah S. Abbas, Eman S. Nossier, May A. El‐Manawaty, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2

Synthesis and Computational Studies of New Pyridine, Pyrazole, Pyran, and Pyranopyrimidine-Based Derivatives of Potential Antimicrobial Activity as DNA Gyrase and Topoisomerase IV Inhibitors
Aisha A. Alsfouk, Ismail M. M. Othman, Manal M. Anwar, et al.
Journal of Molecular Structure (2024) Vol. 1319, pp. 139528-139528
Closed Access | Times Cited: 2

A versatile precursor for one‐pot synthesis of novel azo‐thiazole and thiazole scaffolds as prospective antimicrobial and antioxidant agents
Zahra M. Al-Amshany, Nada Y. Tashkandi, Ismail M. M. Othman
Journal of the Chinese Chemical Society (2024) Vol. 71, Iss. 10, pp. 1309-1323
Open Access | Times Cited: 2

Pyridine-Based Glycosides Bearing 1,2,4-Triazole and Their 1,3,4-oxadiazole analogues as Potential EGFR and CDK-2 Inhibitors: Design, Synthesis, Antiproliferative Activity and In Silico Studies
Asmaa F. Kassem, Ahmed Younis, Eman S. Nossier, et al.
Journal of Molecular Structure (2024) Vol. 1313, pp. 138741-138741
Closed Access | Times Cited: 1

Exploring chemical space, scaffold diversity, and activity landscape of spleen tyrosine kinase active inhibitors
Mohd Danishuddin, Md. Zubbair Malik, Mohammad Kashif, et al.
SAR and QSAR in environmental research (2024) Vol. 35, Iss. 4, pp. 325-342
Closed Access | Times Cited: 1

Design, synthesis, and antimicrobial evaluation of new antipyrine derivatives bearing thiazolopyridazine and pyrazolothiazole scaffolds
Zahra M. Al-Amshany
Synthetic Communications (2023) Vol. 54, Iss. 1, pp. 22-40
Closed Access | Times Cited: 3

Synthesis and Biological Evaluation of Some Fused Pyrrolothiazoles, Pyrazolothiazoles, and Imidazothiazoles
Pankaj Teli, Hemant Kumar Rundla, Lokesh Kumar Agarwal, et al.
(2024), pp. 211-233
Closed Access

Tailor‐Made Pyrazolopyridines and Fused Pyrazolopyridines: Recent Updates toward Sustainable Synthesis
Mohabul A. Mondal, Rina Ghosh
ChemistrySelect (2024) Vol. 9, Iss. 36
Closed Access

Novel Thiazolinone Derivatives: Synthesis, Biological Evaluation, and In Silico Studies
W. O. Alsulami, Zahra M. Al-Amshany, Nada Y. Tashkandi, et al.
Russian Journal of Organic Chemistry (2024) Vol. 60, Iss. 9, pp. 1705-1719
Closed Access

New pyrano-pyridine conjugates as potential anticancer agents: design, synthesis and computational studies
Aladdin M. Srour, Eman S. Nossier, Najla Altwaijry, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 24, pp. 2567-2582
Closed Access

Design, Synthesis, and Docking Simulation of 1,3,4-Thiadiazolyl-Isoindole Thioglycosides and Hydrazinyl Sugar Analogs as Potential Anticancer Agents Targeting EGFR Kinase
Ahd El-Enazy, Mohamed N. El-Bayaa, Walaa I. El-Sofany, et al.
Polycyclic aromatic compounds (2024), pp. 1-19
Closed Access

A Greener Process for the Synthesis of Base‐Catalyzed Substituted Pyrazoles and Triazolopyrimidines as Prospective Biological Activity
Wafa A. Bawazir, Zahra M. Al-Amshany, Reda M. El‐Shishtawy, et al.
ChemistrySelect (2024) Vol. 9, Iss. 48
Closed Access

Page 1

Scroll to top